Rigel Pharmaceuticals
RIGL
#6819
Rank
A$1.08 B
Marketcap
A$57.48
Share price
-13.26%
Change (1 day)
8.11%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2023 (TTM): A-$0.34

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$25.62. In 2022 the company made an earnings per share (EPS) of A-$0.49 a decrease over its 2021 EPS that were of A-$0.14.

EPS history for Rigel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$0.34-31.87%
2022A-$0.49240%
2021A-$0.14-37.5%
2020A-$0.23-60%
2019A-$0.58-11.11%
2018A-$0.65-26.23%
2017A-$0.88-17.57%
2016A-$1.0725.42%
2015A-$0.86-42.72%
2014A-$1.491.98%
2013A-$1.46-24.06%
2012A-$1.93-4.32%
2011A-$2.02-290.41%
2010A$1.06-126.64%
2009A-$3.97-25.14%
2008A-$5.3141.86%
2007A-$3.7470.86%
2006A-$2.19-27.4%
2005A-$3.02-33.33%
2004A-$4.52-37.73%
2003A-$7.26-31.83%
2002A-$10.65-63.55%
2001A-$29.23-96.43%
2000A-$819.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
A$23.51-8.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$9.68-62.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
A-$0.55-102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
A-$2.74-110.70%๐Ÿ‡บ๐Ÿ‡ธ USA